Literature DB >> 8005214

Community-based study of the incidence of gastrointestinal diseases in The Netherlands.

A M Hoogenboom-Verdegaal1, J C de Jong, M During, R Hoogenveen, J A Hoekstra.   

Abstract

The incidence of gastrointestinal diseases was studied in a community-based study in four regions of The Netherlands. Two grades of severity were distinguished--1: diarrhoea or vomiting and at least 2 additional symptoms within the period of 1 week, and 2: diarrhoea or vomiting and at least 2 additional symptoms occurring on the same day lasting at least 2 days within the period of 1 week. The incidence of gastrointestinal episodes was calculated to be 630 for grade 1 and 180 for grade 2 disease per 1000 person-years, after correction for age and sex. The incidence was higher for women than for men (relative risk 1.25) and lower for those in the 19-64-year-old age group when compared to those younger or older (relative risk 0.75 and 0.40, respectively). Independent of the degree of severity of the symptoms, about 20% of the patients had consulted a general practitioner, about half in person and half by telephone. It is concluded that community studies are essential to assess the real incidence of gastrointestinal diseases in the population.

Entities:  

Mesh:

Year:  1994        PMID: 8005214      PMCID: PMC2271516          DOI: 10.1017/s0950268800051189

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  7 in total

1.  A study of illness in a group of Cleveland families. I. Plan of study and certain general observations.

Authors:  J H DINGLE; G F BADGER; A E FELLER; R G HODGES; W S JORDAN; C H RAMMELKAMP
Journal:  Am J Hyg       Date:  1953-07

Review 2.  Diarrhoea in the elderly: epidemiological and aetiological factors.

Authors:  R N Ratnaike
Journal:  J Gastroenterol Hepatol       Date:  1990 Jul-Aug       Impact factor: 4.029

Review 3.  Foodborne illness: an overview.

Authors:  W M Waites; J P Arbuthnott
Journal:  Lancet       Date:  1990-09-22       Impact factor: 79.321

4.  The Tecumseh Study. XI. Occurrence of acute enteric illness in the community.

Authors:  A S Monto; J S Koopman
Journal:  Am J Epidemiol       Date:  1980-09       Impact factor: 4.897

5.  Diarrheal deaths in the United States, 1979 through 1987. A special problem for the elderly.

Authors:  J F Lew; R I Glass; R E Gangarosa; I P Cohen; C Bern; C L Moe
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

6.  The social and economic impact of salmonellosis. A report of a national survey in England and Wales of laboratory-confirmed Salmonella infections.

Authors:  P N Sockett; J A Roberts
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

7.  Policies for control of communicable disease in day care centres.

Authors:  A Chouillet; H Maguire; Z Kurtz
Journal:  Arch Dis Child       Date:  1992-09       Impact factor: 3.791

  7 in total
  18 in total

1.  Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive.

Authors:  J G Wheeler; D Sethi; J M Cowden; P G Wall; L C Rodrigues; D S Tompkins; M J Hudson; P J Roderick
Journal:  BMJ       Date:  1999-04-17

2.  Syndromic surveillance of gastrointestinal illness using pharmacy over-the-counter sales. A retrospective study of waterborne outbreaks in Saskatchewan and Ontario.

Authors:  Victoria L Edge; Frank Pollari; Gillian Lim; Jeff Aramini; Paul Sockett; S Wayne Martin; Jeff Wilson; Andrea Ellis
Journal:  Can J Public Health       Date:  2004 Nov-Dec

3.  The magnitude and distribution of infectious intestinal disease in Malta: a population-based study.

Authors:  C Gauci; H Gilles; S O'brien; J Mamo; I Stabile; F M Ruggeri; A Gatt; N Calleja; G Spiteri
Journal:  Epidemiol Infect       Date:  2007-01-15       Impact factor: 2.451

4.  Domestic and travel-related foodborne gastrointestinal illness in a population health survey.

Authors:  M R Evans; T Sarvotham; D R Thomas; A J Howard
Journal:  Epidemiol Infect       Date:  2006-01-25       Impact factor: 2.451

5.  The burden of acute gastrointestinal illness in Ontario, Canada, 2005-2006.

Authors:  J M Sargeant; S E Majowicz; J Snelgrove
Journal:  Epidemiol Infect       Date:  2007-06-13       Impact factor: 2.451

6.  Syndromic Surveillance of Norovirus using Over-the-counter Sales of Medications Related to Gastrointestinal Illness.

Authors:  Victoria L Edge; Frank Pollari; Lai King Ng; Pascal Michel; Scott A McEwen; Jeffrey B Wilson; Michael Jerrett; Paul N Sockett; S Wayne Martin
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-07       Impact factor: 2.471

7.  Enteropathogens in acute diarrhea: a general practice-based study in a Nordic country.

Authors:  I Hilmarsdóttir; G E Baldvinsdóttir; H Harðardóttir; H Briem; S I Sigurðsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-05       Impact factor: 3.267

8.  A population-based longitudinal study on the incidence and disease burden of gastroenteritis and Campylobacter and Salmonella infection in four regions of The Netherlands.

Authors:  M A de Wit; A M Hoogenboom-Verdegaal; E S Goosen; M J Sprenger; M W Borgdorff
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

9.  Gastroenteritis in sentinel general practices,The Netherlands.

Authors:  M A de Wit; M P Koopmans; L M Kortbeek; N J van Leeuwen; A I Bartelds; Y T van Duynhoven
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

10.  Methods for determining disease burden and calibrating national surveillance data in the United Kingdom: the second study of infectious intestinal disease in the community (IID2 study).

Authors:  Sarah J O'Brien; Greta Rait; Paul R Hunter; James J Gray; Frederick J Bolton; David S Tompkins; Jim McLauchlin; Louise H Letley; Goutam K Adak; John M Cowden; Meirion R Evans; Keith R Neal; Gillian E Smith; Brian Smyth; Clarence C Tam; Laura C Rodrigues
Journal:  BMC Med Res Methodol       Date:  2010-05-05       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.